These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21078949)

  • 1. Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
    Shimizu-Ibuka A; Oishi M; Yamada S; Ishii Y; Mura K; Sakai H; Matsuzawa H
    Antimicrob Agents Chemother; 2011 Jan; 55(1):284-90. PubMed ID: 21078949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
    Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
    Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
    Ishii Y; Ohno A; Taguchi H; Imajo S; Ishiguro M; Matsuzawa H
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An engineered disulfide bond between residues 69 and 238 in extended-spectrum beta-lactamase Toho-1 reduces its activity toward third-generation cephalosporins.
    Shimizu-Ibuka A; Matsuzawa H; Sakai H
    Biochemistry; 2004 Dec; 43(50):15737-45. PubMed ID: 15595829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
    Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of disulfide-bond introduction on the activity and stability of the extended-spectrum class A beta-lactamase Toho-1.
    Shimizu-Ibuka A; Matsuzawa H; Sakai H
    Biochim Biophys Acta; 2006 Aug; 1764(8):1349-55. PubMed ID: 16890032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the Mycobacterium fortuitum class A beta-lactamase: structural basis for broad substrate specificity.
    Sauvage E; Fonzé E; Quinting B; Galleni M; Frère JM; Charlier P
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2516-21. PubMed ID: 16801434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of serine 237 in class A beta-lactamase of Proteus vulgaris modifies its unique substrate specificity.
    Tamaki M; Nukaga M; Sawai T
    Biochemistry; 1994 Aug; 33(33):10200-6. PubMed ID: 8060986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam.
    Ma L; Ishii Y; Ishiguro M; Matsuzawa H; Yamaguchi K
    Antimicrob Agents Chemother; 1998 May; 42(5):1181-6. PubMed ID: 9593147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis.
    Brown NG; Shanker S; Prasad BV; Palzkill T
    J Biol Chem; 2009 Nov; 284(48):33703-12. PubMed ID: 19812041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.
    Majiduddin FK; Palzkill T
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3421-7. PubMed ID: 16048956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain.
    Sabaté M; Tarragó R; Navarro F; Miró E; Vergés C; Barbé J; Prats G
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1970-3. PubMed ID: 10858363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evolution of a class C beta-lactamase extending its substrate specificity.
    Nukaga M; Haruta S; Tanimoto K; Kogure K; Taniguchi K; Tamaki M; Sawai T
    J Biol Chem; 1995 Mar; 270(11):5729-35. PubMed ID: 7890700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The catalytic efficiency (kcat/Km) of the class A beta-lactamase Toho-1 correlates with the thermal stability of its catalytic intermediate analog.
    Nitanai Y; Shimamura T; Uchiyama T; Ishii Y; Takehira M; Yutani K; Matsuzawa H; Miyano M
    Biochim Biophys Acta; 2010 Apr; 1804(4):684-91. PubMed ID: 19883800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance.
    Lu S; Montoya M; Hu L; Neetu N; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2023 May; 299(5):104630. PubMed ID: 36963495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis.
    Pérez-Llarena FJ; Kerff F; Abián O; Mallo S; Fernández MC; Galleni M; Sancho J; Bou G
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4361-8. PubMed ID: 21730121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.
    Ibuka A; Taguchi A; Ishiguro M; Fushinobu S; Ishii Y; Kamitori S; Okuyama K; Yamaguchi K; Konno M; Matsuzawa H
    J Mol Biol; 1999 Feb; 285(5):2079-87. PubMed ID: 9925786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics.
    Majiduddin FK; Palzkill T
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1062-7. PubMed ID: 12604542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin.
    Shimamura T; Ibuka A; Fushinobu S; Wakagi T; Ishiguro M; Ishii Y; Matsuzawa H
    J Biol Chem; 2002 Nov; 277(48):46601-8. PubMed ID: 12221102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.